Articles in Peer-reviewed journals:

Scalia P, Giordano A, Martini C, Williams SJ. Isoform switching in IR signaling: when diabetes open the gates to Cancer (review). Biomolecules 2021, in press (IF 4.694)-> Scopus

Scalia P, Heart E, Doughty A, Giordano A, Williams SJ. 2020. Vitronectin Negatively regulates IGF-II-Induced Mitogenic Signaling and Migration mediated by The Insulin Receptor Isoform-A. Intl J Appl Biol Pharm Tech,

Scalia P, Williams SJ, Ventura E, Stanganelli I, Giordano A, Ferrau’ F, Asero S. 2020. The Oncogenomic Landscape of Malignant Melanoma: The Tumor Microenvironment Comes of Age (review). J Cancer Res Oncobiol,

Scalia P, Williams SJ, Luca’ R, Giordano A, Bucci E. 2020. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication (review). Eur J Mol Clin Med, 7(1), pp. 05–09, DOI: ->Scopus

Scalia P and Williams SJ. An Expert Patients-for-Patients integrated Biobanking-CRO Operational Model For Sustainable Personalized Oncology. Biomed J Sci Tech Res, 2020 Published on March 11th; Doi 10.26717/BJSTR.2020.26.004367 (IF 0.53).

Scalia, P.; Giordano, A.; Williams, S.J. The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives (review). Cancers 2020, 12(2), 366. Doi: 10.3390/cancers12020366 (IF 6.162) ->Scopus

Scalia P, Williams SJ, Giordano A. Core elements cloning, cis-elements mapping and serum regulation of the Human EphB4 Promoter: A Novel TATA-Less Inr/MTE/DPE-like Regulated Gene. Genes, 2019,10, 997; doi:10.3390/genes10120997 (IF 3.33)->Scopus

Scalia P, Pandini G, Carnevale V, Giordano A, Williams SJ Identification of a Novel EphB4 Phosphodegron Regulated by the Autocrine IGFII/IRA Axis in Malignant Mesothelioma. Oncogene, 2019, 38:5987-6001. doi: 10.1038/s41388-019-0854-y
(IF 6.634)-> Scopus

Chapters in textbooks:

Scalia P, Williams SJ, Russo A, Giordano A. 2017. Actionable Molecular Targets in Cancer Liquid Biopsy (Chapter in Book), p 71-76. Liquid Biopsy in Cancer Patients: The Hand Lens for Tumor Evolution. Ed. Russo, Giordano & Rolfo. Humana Press, 2017. ISBN 978-3-319-55659

Presentations at congresses (by Invitation)

Scalia P. Identification of a novel EphB4-Kinase phosphodegron and characterization of its degradation complex regulated by the Autocrine IGF-II-IR/A axis: A Critical Molecular Checkpoint In Malignant Mesothelioma. 21st Natl scientific Congress, Gruppo Oncologico Italia Meridionale (GOIM), Catania July 27th-29th, 2019

Scalia P. Actionable Molecular Oncology Targets in Tissue High Content Screening Platform: Moving Proteomics Profiling to the Patient Bed. Tissue Microarray Workshop in Quantitative Digital Proteomics in Pathology. Philadelphia, USA, Children Hospital of Philadelphia, University of Pennsylvania, Buerger Center, November 17, 2017

Scalia P. Biobanking of Solid Tumors for Research & in Predictive-Preventive Screening: Limits & Perspectives. Convention of the Regional Oncologic Network, Sicily, CEFPAS Campus, Caltanissetta, Italy, April 10th, 2015

Scalia P. Combined use of Laser Capture Microdissection and Geno-transcriptomic Analysis for cancer fingerprinting. Convention on “The Evolution of Molecular Biology in Anatomic Pathology”, Palermo, Italy, Hospital ARNAS Civico, June 24th 2015

Scalia P. Onco-genomics and signaling pathways in the clonal evolution induced by drug- resistance in melanoma. 1st Mediterranean congress on New Therapies in the Treatment of Melanoma. Palermo, Italy, Palazzo Steri, September 11th & 12th,2015

Scalia P and Lo Presti G. Synergistic Data Integration in the Age of Personalized Medicine. ESBB-LIMS Workshop, Milano, Italy, March 13-14, 2014.

Last update on December 2020

Research publications

Updated on 2020-12-22T18:54:34+00:00, by Pierluigi Scalia.